The pandemic has fuelled investor interest in biotech, life sciences and drug discovery with state-owned investors ploughing more than US$5.5 billion into the space so far this year, mostly in the form of venture capital for startups – an increase of 53% over the whole of 2020.Overall venture capital investment...
The pandemic has fuelled investor interest in biotech, life sciences and drug discovery with state-owned investors ploughing more than US$5.5 billion into the space so far this year, mostly in the form of venture capital for startups – an increase of 53% over the whole of 2020.Overall venture capital investment...